Ignite Creation Date:
2024-05-06 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02759835
Status:
COMPLETED
Last Update Posted:
2024-06-07
First Post:
2016-04-06
Brief Title:
Local Ablative Therapy for Treatment of Oligoprogressive EGFR-Mutated Non-Small Cell Lung Cancer After Treatment With Osimertinib
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
160092
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
Azam Ghafoor
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Cancer Institute NCI
Old Name:
None
Old Organization:
None